sudarshan pharma

Auto Added by WPeMatico

BSE Business earnings Net Profit pharmaceutical Q2 FY27 revenue sudarshan pharma

Sudarshan Pharma Q2 Profit Surges 86% to Rs 7.78 Crore; Revenue Jumps 28% as Margins Improve

New Delhi [India], October 30: Sudarshan Pharma Industries Ltd has reported strong financial performance for the second quarter of FY27, with consolidated net profit surging 86.12% year-on-year to ₹7.78 crore, compared with ₹4.18 crore in the corresponding quarter of the previous financial year. The company’s consolidated revenue increased 28.48% to ₹216.97 crore during the July–September […]

9.5% stake due diligence fema Finance hemal mehta med therapy medtherapy biotechnology overseas investment sachin mehta sebi lodr sudarshan pharma

Sudarshan Pharma Says Proposed 9.5% Stake Acquisition in US Firm Under Due Diligence

New Delhi [India], September 15: Sudarshan Pharma Industries Ltd has provided an update on its proposed acquisition of a 9.5% equity stake in US-based Med Therapy Biotechnology Inc., stating that the transaction is currently under due diligence. In a regulatory filing dated September 15, the company said the proposal to acquire the 9.5% stake in […]

Growing Up Around Startups, 17-Year-Old Arjit Aggarwal Is Bringing Entrepreneurship to Classrooms

Kisan Maharaj Awards 2026 Celebrates Agricultural Excellence in Hyderabad

Dr. Shankar Andani Completes Professional PhD by Publication in Taxation

Sudarshan Pharma Q2 Profit Surges 86% to Rs 7.78 Crore; Revenue Jumps 28% as Margins Improve

Brahamastra, Part of Lord’s Mark Industries Limited, Takes Indigenous Defence Innovation to the Global Stage

sudarshan pharma

Sudarshan Pharma Q2 Profit Surges 86% to Rs 7.78 Crore; Revenue Jumps 28% as Margins Improve

Sudarshan Pharma Says Proposed 9.5% Stake Acquisition in US Firm Under Due Diligence